Cardiff Oncology Shares Face Sustained Selling Pressure

Elevated Trading Activity Signals Concern

Cardiff Oncology’s stock continues to navigate challenging market conditions, with its downward trajectory becoming increasingly pronounced. The share price concluded the recent session at $2.04, marking another step in a consistent pattern of declines.

Trading activity on Thursday highlighted significant investor unease. The stock declined by 1.45%, fluctuating within a range of $1.96 to $2.08. This intraday swing of nearly 6% underscores the current volatility. A broader look reveals a clear bearish trend, with six of the last ten trading sessions closing in negative territory. Key technical indicators further corroborate this negative momentum.